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Abstract
Background/aims: Distal pancreatectomy (DP) is performed for a range of benign and malignant
lesions. Accurate pre-operative diagnosis can be unreliable and morbidity remains high. This study
evaluates a 12-year, single-centre experience with open DP to review indications, diagnoses and asso-
ciated morbidity.
Methods: Retrospective review of patients who underwent DP at a UK-based tertiary referral centre
between 1994 and 2006.
Results: Sixty-five patients (mean age 49.9 years) had final diagnoses of chronic pancreatitis 
pseudocyst (n = 22), benign cystadenoma (n = 15), neuroendocrine tumour (n = 8), primary pancreatic
carcinoma (n = 6) and 14 other conditions. DP performed for presumed cystic neoplasm (n = 24) revealed
a correct pre-operative diagnosis in 71% of patients. Histological examination confirmed that 59% of
resected cystic tumours were either malignant or had malignant potential. When DP was undertaken for
presumed pseudocyst (n = 12), 83% of cases were correctly diagnosed pre-operatively. Overall mortality
and morbidity rates were 3% and 39%, respectively, with five patients (8%) developing a clinically
significant pancreatic fistula. Ten (17%) patients developed diabetes mellitus and nine (14%) required
long-term pancreatic exocrine supplementation.
Conclusions: Open DP can be performed with acceptable morbidity, low mortality and preservation of
pancreatic function in the majority of cases, setting the standard for laparoscopic techniques.
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Introduction
Distal pancreatectomy (DP), involving resection of the pancreas
to the left of the superior mesenteric vessels, is performed for a
range of benign and malignant lesions, trauma and inflammatory
disorders. In recent years, the procedure has been increasingly
performed by laparoscopic means, although published series are
small and report comparatively high morbidity.1,2 Accurate pre-
operative diagnosis of pancreatic lesions, especially differentiating
malignant and non-malignant cystic neoplasms, can be unreliable
and is often only possible after detailed pathological examination.3
However, the reported high incidence of malignant tumours and
tumours with malignant potential often favours resection over
conservative management.4
Distal pancreatectomy was first described over a century ago,
however, resection rates have shown little increase over this time
despite the introduction of laparoscopic approaches to treat-
ment.1,5 This may relate to the relative infrequency of potentially
resectable distal pancreatic lesions, the complexity of the proce-
dure and high post-operative morbidity, especially pancreatic
fistula.6 Over recent years, attempts to reduce post-operative
pancreatic fistula (POPF) have focussed on methods of distal
pancreatic remnant closure (staple, suture, duct ligation or a
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combination) and the use of somatostatin analogues to inhibit
exocrine secretion of the pancreas although results are
inconclusive.6,7
This study aims to review a 12-year, single-centre experience
with DP, providing a background on which to discuss the emerg-
ing technique of laparoscopic DP.
Patients and methods
A retrospective review of cases coded as distal pancreatectomy in
the Lothian surgical audit database was undertaken. The Lothian
Surgical Audit recorded all surgical activity at a UK-based tertiary
referral centre, between August 1994 and August 2006. Admission
records, operation details, pathology records and clinic notes were
reviewed for each available case and the presenting complaint,
pre-operative investigations, operative technique, final diagnosis
and post-operative outcome were recorded.
Definitions
The ISGPF definition (International study group: pancreatic
fistula, 2005) of POPF was used i.e. drain amylase concentration
three times serum amylase on or after post-operative day three.8
The ISGPF definition further categorizes fistulae according to a
range of parameters into ‘Grade A’ – a transient fistula of no
clinical consequence, ‘Grade B’ – requiring deviation from routine
management and ‘Grade C’ – requiring major deviation from
routine management and aggressive intervention (Table 1). Only
clinically significant POPF grade B and C were recorded in this
study.
Post-operative morbidity was defined as any complication
arising in the 30-day post-operative period. Pancreatic endocrine
and exocrine deficiencies were defined as the requirement for
endocrine or exocrine supplementation during the follow-up
period where pancreatic deficiency was not present pre-
operatively.
Statistical analysis
Data analysis was performed using SPSS version 11 (SPSS Inc.,
Chicago, IL, USA). Student’s t-test was used to compare differ-
ences between length of stay. Chi-square analysis assessed differ-
ences in complication rates between procedural variations (i.e.
stump closure technique). The level of significance was set at
P < 0.05.
Results
Seventy-six cases were coded as ‘distal pancreatectomy’ in the
Lothian Surgical Audit database. Eleven were excluded either
because of miscoding (n = 5) or incomplete case details (n = 6).
The final group of 65 patients (40 females and 25 males) had a
mean age of 49.9 years (range 15–88).
Presentation
The mode of presentation to the surgical team included abdomi-
nal pain (n = 37), pancreatic lesion noted on CT for evaluation of
suspected non-pancreatic intra-abdominal malignancy (n = 8),
symptoms of hypoglycaemia (n = 6), incidental finding on CT (n
= 5), trauma (n = 3), pleural effusion (n = 2), gastrointestinal bleed
(n = 2), painless jaundice (n = 1) and abdominal mass (n = 1).
Computed tomography (CT) scanning was performed in all
patients. Other investigations included endoscopic retrograde
cholangiopancreatography (ERCP) (n = 8), exploratory laparos-
copy +/- ultrasound (n = 6), endoscopic ultrasound (n = 4) and
magnetic resonance imaging (MRI) (n = 1). The principal indica-
tions for DP included presumed cystic neoplasia (n = 23), pre-
sumed non-cystic neoplasia (n = 19) and presumed pseudocyst/
chronic pancreatitis (n = 15) (Fig. 1).
Operative details
During the study period, 65 procedures were performed. Intra-
operative ultrasound of the pancreas was used to assess the cystic
lesions in 31 patients. Closure of the pancreatic stump involved
suture plus duct ligation (n = 34), suture alone (n = 19) or staple
plus suture (n = 12). Additional procedures included splenectomy
(n = 40), splenectomy plus cholecystectomy (n = 5), splenectomy
plus partial gastrectomy (n = 5), left hemicolectomy (n = 3) and
cholecystectomy alone (n = 2). Spleen preserving DP without
Table 1 The main parameters for post-operative pancreatic fistula (POPF) grading according to ISGPF definition8
Grade A B C
Clinical conditions Well Often well Ill appearing/bad
Specific treatment No Yes/no Yes
US/CT Negative Negative/positive Positive
Persistent drainage No Usually yes Yes
Reoperation No No Yes
Death related to POPF No No Possibly yes
Signs of infection No Yes Yes
Sepsis No No Yes
Readmission No Yes/no Yes/no
US, ultrasound; CT, computed tomography; POPF, post-operative pancreatic fistula
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additional procedure was performed in eight patients. Peri-
operative octreotide was administered in five cases, based on
individual clinician decision, with dosing regimens ranging from
100–250 mg (three times a day) for 3 to 5 days.
Pancreatic pathology
Pancreatic pathology included chronic pancreatitis and/or
pseudocyst (n = 22), benign cystadenoma (n = 15), neuroendo-
crine tumour (n = 8), primary pancreatic carcinoma (n = 5), no
abnormalities (n = 4), trauma (n = 3), acute pancreatitis (n = 2),
metastatic carcinoma (n = 2), simple cyst (n = 2), gastrointestinal
stromal tumour (GIST) (n = 1) and malignant local invasion (n =
1). Of the neuroendocrine tumours, three showed malignant
change.
DP performed for presumed cystic neoplasia (n = 24) revealed
a correct pre-operative diagnosis in 71% of patients with other
diagnoses including pseudocyst (n = 6) and chronic pancreatitis
(n = 1). Histological examination confirmed that 10 out of the
17 (59%) resected cystic tumours were either malignant or pos-
sessed malignant potential. Ten out of the 12 (83%) presumed
pseudocysts were diagnosed correctly pre-operatively. The patho-
logical findings in those patients with incidental distal pancreatic
lesions included mucinous cystadenoma (n = 2), primary adeno-
carcinoma (n = 1), serous cystadenoma (n = 1) and chronic pan-
creatitis (n = 1). In the four cases where no histological pancreatic
abnormality was identified, the reasons for resection included
known colonic carcinoma with presumed pancreatic invasion (n =
2), presumed neoplasm noted on CT (n = 1) and presumed
chronic pancreatitis (n = 1).
Post-operative course
The median post-operative hospital stay was 10 days (range 5–64
days). The morbidity and length of stay increased significantly
when procedures unrelated to DP (cholecystectomy/gastrectomy/
colectomy) were performed (P = 0.049). There was no significant
difference in length of stay between spleen preserving DP and DP
with splenectomy (P = 0.346).
Overallmortality andmorbidity rateswere 3%and 39%, respec-
tively. Mortality (n = 2) was related to post-operative intra-
abdominal haemorrhage (n= 1) and acute pancreatitis (n= 1). Five
patients (8%) developed POPF grade B with ultrasound +/- CT
evidence of a pancreatic fistula (n = 3) or peripancreatic collection
(n = 2). Additional procedures (n = 4) included splenectomy alone
(n = 2), left hemicolectomy (n = 1) and splenectomy plus partial
gastrectomy (n = 1). Diagnoses in these cases included mucinous
cystadenoma (n = 2), trauma (n = 2) and normal pancreas (n = 1).
After prolonged intra-abdominal drainage, all resolved spontane-
ously without further intervention (median length of drainage 18
days; range 10–56 days). There was no difference in length of
hospital stay between the POPF B and non-POPF group (t = 1.05;
P = 0.342). There was no association between pancreatic stump
closure (staple and suture; suture and duct ligation; suture alone)
and POPF B (P = 0.814). No patients developed POPF grade C.
Non-pancreatic complications included pulmonary embolus (n =
4), wound infection (n = 3), pneumonia (n = 2), ruptured spleen
requiring splenectomy (n = 1) and miscellaneous (n = 8).
The median duration of follow up was 8.5 months (range 2–64
months). Nine patients required readmission for pain control [DP
indication: intra-abdominal malignancy (n = 4), pseudocyst (n =
4) and chronic pancreatitis (n = 1)] and two patients were read-
mitted for treatment of a wound infection. During the follow-up
period, pancreatic endocrine deficiency developed in 11 patients
(17%), requiring either insulin (n = 9) or an oral hypoglycaemic
agent (n = 2). Pancreatic exocrine deficiency developed in nine
patients (14%) requiring pancreatic exocrine supplementation.
Four patients developed both endocrine and exocrine deficiencies.
In six cases of post-operative pancreatic insufficiency, the resected
specimen revealed chronic pancreatitis and/or pseudocyst.
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Figure 1 Main indications for distal pancreatectomy (DP) over the study period (miscellaneous indications excluded). NB ‘Year’ represents
August to August
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Discussion
This study represents a comprehensive long-term review of distal
pancreatectomy at a UK-based tertiary referral centre, providing a
background for which the development of laparoscopic tech-
niques in DP may be compared. While advances in preoperative
imaging, surgical technique and peri-operative management over
recent years may have enhanced resection rates for other pancre-
atic procedures,5 DP rates have remained static. The reason is
likely to be multifactorial with limiting factors including the rela-
tive infrequency of distal pancreatic lesions and delayed presenta-
tion of distal pancreatic neoplasia.9 There is a suggestion of
changing indications for DP possibly reflecting trends towards
more conservative management of chronic pancreatitis with an
increased number of cystic lesions noted using modern CT imag-
ing.10 Indeed distal pancreatectomy is now rarely performed for
chronic pancreatitis given the high rate of pain recurrence.
The increasing number of incidental pancreatic lesions
reported by some centres, often in young individuals, has lead to a
greater demand for laparoscopic DP, minimizing surgical inter-
vention and targeting tumour eradication.11 In our series, the
incidental finding of suspicious pancreatic lesions on CT imaging
represented an important minority, with three out of five inciden-
tal lesions later shown to be premalignant or malignant. Accurate
pre-operative diagnosis is vital in identifying appropriate surgical
candidates and it is important that the potential benefits of
minimal access surgery do not influence previous operative
indications.11 In this series, approximately one-third of presumed
cystic neoplasms were found to be non-neoplastic, suggesting that
this subgroup may benefit from more invasive pre-operative
investigation. Endoscopic ultrasound in combination with fine-
needle biopsy and analysis of cystic fluid represents the most
accurate pre-operative technique to differentiate benign from pre-
malignant or malignant cystic lesions.12 In a recent multicentre
trial, Brugge et al. demonstrated that carcinoembryonic antigen
(CEA) was the most accurate indicator of pre-malignant or malig-
nant cystic lesions using an optimal CEA cut-off level of 192 ng/
ml.13 Cystic fluid CEA is significantly more accurate than cytology,
morphology or any other combination of cystic fluid markers.13
Endoscopic ultrasound of distal pancreatic lesions is now being
performed more regularly and may prove a valuable adjunct to
current pre-operative assessment.
Despite the improved post-operative course and minimal cos-
metic impact of laparoscopic techniques, the adequacy of laparo-
scopic procedures to assess, stage and resect malignant pancreatic
lesions is uncertain. This has resulted in high rates of conversion to
open DP when suspicious lesions have been noted intra-
operatively.14,15 Previously, pancreatic malignancy has been
regarded as a contraindication to laparoscopic resection, however,
Fernandez-Cruz et al. demonstrated adequate resection margins
in a small series of pancreatic neuroendocrine malignancies.15
Despite these promising results, long-term outcome data are still
not available. In addition, it is not yet possible to quantify
laparoscopic-specific risks inDP, such as port sitemetastasis,which
have limited laparoscopic resection of other intra-abdominal can-
cers.16 Given the number of incidental lesions detected by modern
imaging modalities and the difficulties in pre-operative diagnosis,
a minimally invasive alternative for resection is certainly attractive
and is more commonly being undertaken.
POPF simply represents a leak from the pancreatic remnant;
however, more than 26 individual centre definitions have been
reportedmaking inter-centre comparisonproblematic.8 This distal
pancreatectomy series presents incidence of POPFusing the ISGPF
definition with an overall grade B fistula rate of 8% (5% if trauma
cases are excluded). The recent standardization of POPF is an
important development in the assessment of pancreatic complica-
tions and should now form the accepted method of classification,
allowing meaningful comparison between laparoscopic and open
techniques. The ISGPF definition has received criticism relating to
its dependence on subjective opinion and broad categorization.17
However, the definition provides a concise system to differentiate
so-called ‘transient fistulae’ with no clinical sequelae and fistulae
resulting in deviation from routine management.18 Previous
studies report POPF rates of between 5% and 34% after open DP,
depending on the definition used.19 In a recentmulticentre series of
46 laparoscopic DP, POPF developed in 15%, requiring either
prolonged (n = 5) or percutaneous drainage (n = 2).14 The authors
of the largest multicentre laparoscopic DP series to date (n = 82)
commented on their high rate of pancreatic complications when
compared with open procedures, especially pancreatic fistula.20
The current study is limited by the exclusion of POPF Grade A
(clinically insignificant fistulae) and this relates to retrospective
data collection. As no association has been demonstrated between
transient POPF and morbidity, it is questionable whether a clini-
cally inconsequential finding shouldbe included inmorbidity data.
Selecting the most efficacious closure method of the pancreatic
stump is limited by the lack of large randomized controlled trials.
While no clear favourite has been established, a recent meta-
analysis reported a trend in favour of staple closure.6 Identification
and ligation of the pancreatic duct may not always be feasible but
is the only significantly beneficial technique reported to date.21 In
laparoscopic DP, the pancreatic stump is generally stapled as a
result of the technical challenge of duct identification and ligation,
possibly accounting for the high fistula rates reported.20 This series
showed no difference between remnant closure techniques as
reported in other retrospective studies.22 The low POPF rate may
reflect the authors aim to routinely ligate the pancreatic duct and
oversew the stump. Regardless of closure method, careful surgical
technique is perhaps the major factor in minimizing POPF.
The use of somatostatin analogues to reduce POPF by reducing
exocrine pancreatic secretion remains controversial. A recent
meta-analysis by Connor et al. identified three small trials (n < 70)
where somatostatin analogues were evaluated in DP showing no
significant benefit over placebo.7 These trials did not categorize
DP by indication or pathology and this may prove useful in tar-
geting specific subgroups. Assessing the efficacy of somatostatin
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analogues in this study was not possible owing to the subjective
indications for their administration; however, the continuing lack
of evidence may limit their use further. Large multicentre trials are
clearly indicated.
A recent small observational study (n = 9) suggested that pre-
operative stenting of the pancreatic duct with the aim of reducing
intraductal pressure may prevent POPF.23 This feasibility study
was not sufficient to draw conclusions although the risks of endo-
scopic stenting, such as pancreatitis and stent blockage, may out-
weigh potential benefits.
Evaluating pancreatic remnant exocrine and endocrine function
has received limited attention with only two studies assessing post
DP pancreatic function. In a US study of 235 patients who under-
went DP, 8% developed diabetes over an unspecified period.5
Hutchins et al. looked specifically at DP for chronic pancreatitis
and using objective exocrine and endocrine assessment reported
deficiency rates of 60%and43%,respectively.24 This study reported
a 14%exocrine and17%endocrinedeficiency rate basedon clinical
evaluation at follow up. The variation is clearly accounted for by
methodological variance andpatient group, resulting in difficulties
with study comparison. Evaluating pancreatic remnant dysfunc-
tionmay be beneficial to provide improved pre-operative informa-
tion to patients; however, further research is required in this area.
In conclusion, distal pancreatectomy can be performed for a
wide range of pancreatic disorders with low mortality, acceptable
morbidity and preservation of pancreatic function in the majority
of cases. The management of distal pancreatic cystic lesions may
benefit from pre-operative endoscopic ultrasound and evaluation
of aspirate CEA levels. Laparoscopic techniques have the potential
to further improve the post-operative course, although specific
indications should be considered and the comparatively high pan-
creatic fistula rates need to be addressed.
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